TGF-β1 calcium signaling in osteoblasts

Journal of Cellular Biochemistry

Volumn 101, Issue 2, 2007, Pages 348-359

  Nesti, Leon J ^a,b   Caterson, E J ^c   Li, Wan Ju ^b   Chang, Richard ^d   McCann, Thane D ^a,d   Hoek, Jan B ^d   Tuan, Rocky S ^b,d,e  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Ca 2+ channel; Ca2+ signaling; Cell adhesion; Fura 2; Osteoblast; Smad; TGF 1

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; NIFEDIPINE; POLYSTYRENE; SMAD PROTEIN; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA1; ENZYME INHIBITOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; EXTRACELLULAR FLUID; HUMAN; HUMAN TISSUE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; CALCIUM; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL ADHESION; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; NIFEDIPINE; OSTEOBLASTS; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34247877589     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21180     Document Type: Article

References (60)

1. Advincula MC, Rahemtulla FG, Advincula RC, Ada ET, Lemons JE, Bellis SL. 2006. Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide. Biomaterials 27:2201-2212.
2. Alevizopoulos A, Mermod N. 1997. Transforming growth factor-beta: The breaking open of a black box. Bioessays 19:581-591.
3. Alevizopoulos A, Dusserre Y, Ruegg U, Mermod N. 1997. Regulation of the transforming growth factor beta-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV. J Biol Chem 272:23597-23605.
4. Barry EL. 2000. Expression of mRNAs for the alpha 1 subunit of voltage-gated calcium channels in human osteoblast-like cell lines and in normal human osteoblasts. Calcif Tissue Int 66:145-150.
5. Barry EL, Gesek FA, Froehner SC, Friedman PA. 1995. Multiple calcium channel transcripts in rat osteosarcoma cells: Selective activation of alpha 1D isoform by parathyroid hormone. Proc Natl Acad Sci USA 92:10914-10918.
6. Blobe GC, Schiemann WP, Lodish HF. 2000. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358.
7. Bonewald LF, Kester MB, Schwartz Z, Swain LD, Khare A, Johnson TL, Leach RJ, Boyan BD. 1992. Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267:8943-8949.
8. Bouvard D, Block MR. 1998. Calcium/calmodulin-dependent protein kinase II controls integrin alpha5beta1-mediated cell adhesion through the integrin cytoplasmic domain associated protein-1alpha. Biochem Biophys Res Commun 252:46-50.
9. Branemark PI, Hansson BO, Adell R, Breine U, Lindstrom J, Hallen O, Ohman A. 1977. Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl 16:1-132.
10. Centrella M, McCarthy TL, Canalis E. 1987. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874.
11. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. 1994. Transforming growth factor-beta gene family members and bone. Endocr Rev 15:27-39.
12. Chen TL, Bates RL, Dudley A, Hammonds RG, Jr., Amento EP. 1991. Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-beta 1. J Bone Miner Res 6:1387-1393.
13. Dallas SL, Sivakumar P, Jones CJ, Chen Q, Peters DM, Mosher DF, Humphries MJ, Kielty CM. 2005. Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1. J Biol Chem 280:18871-18880.
14. Dean DC, Newby RF, Bourgeois S. 1988. Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines. J Cell Biol 106:2159-2170.
15. Duncan RL, Akanbi KA, Farach-Carson MC. 1998. Calcium signals and calcium channels in osteoblastic cells. Semin Nephrol 18:178-190.
16. El-Amin SF, Botchwey E, Tuli R, Kofron MD, Mesfin A, Sethuraman S, Tuan RS, Laurencin CT. 2006. Human osteoblast cells: Isolation, characterization, and growth on polymers for musculoskeletal tissue engineering. J Biomed Mater Res A 76:439-449.
17. Faler BJ, Macsata RA, Plummer D, Mishra L, Sidawy AN. 2006. Focus on basic science: Transforming growth factor-beta and wound healing. Perspect Vasc Surg Endovasc Ther 18:55-62.
18. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799.
19. Harbers GM, Healy KE. 2005. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res A 75:855-869.
20. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR. 1994. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863.
21. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. 1989. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 264:380-388.
22. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
23. Hill CS. 1996. Signalling to the nucleus by members of the transforming growth factor-beta (TGF-beta) superfamily. Cell Signal 8:533-544.
24. Hill CS. 2006. Turning off Smads: Identification of a Smad phosphatase. Dev Cell 10:412-413.
25. Hock JM, Canalis E, Centrella M. 1990. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126:421-426.
26. Huang SS, Huang JS. 2005. TGF-beta control of cell proliferation. J Cell Biochem 96:447-462.
27. Ignotz RA, Massague J. 1987. Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell 51:189-197.
28. Ishiyama N, Shibata H, Kanzaki M, Shiozaki S, Miyazaki J, Kobayashi I, Kojima I. 1996. Calcium as a second messenger of the action of transforming growth factor-beta on insulin secretion. Mol Cell Endocrinol 117:1-6.
29. Javelaud D, Mauviel A. 2005. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: Implications for carcinogenesis. Oncogene 24:5742-5750.
30. Lee JY, Kim KH, Shin SY, Rhyu IC, Lee YM, Park YJ, Chung CP, Lee SJ. 2006. Enhanced bone formation by transforming growth factor-beta1-releasing collagen/chitosan microgranules. J Biomed Mater Res A 76:530-539.
31. Loza J, Stephan E, Dolce C, Dziak R, Simasko S. 1994. Calcium currents in osteoblastic cells: Dependence upon cellular growth stage. Calcif Tissue Int 55:128-133.
32. Meszaros JG, Karin NJ, Farach-Carson MC. 1996. Voltage-sensitive calcium channels in osteoblasts: Mediators of plasma membrane signalling events. Connect Tissue Res 35:107-111.
33. Mundy G, Harris S, Sabatini M, Gutierrez G, Garrett I, Izbicka E. 1993. The use of osteosarcoma cells to characterize factors which regulate bone cells function. In: Novack J, McMaster J, editors. Frontiers of osteosarcoma research. Seattle: Hogrefe and Huber. pp 449-456.
34. Nesti LJ, Caterson EJ, Wang M, Chang R, Chapovsky F, Hoek JB, Tuan RS. 2002. TGF-beta1 calcium signaling increases alpha5 integrin expression in osteoblasts. J Orthop Res 20:1042-1049.
35. Noda M, Rodan GA. 1986. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun 140:56-65.
36. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS. 2003. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201-211.
37. Oide H, Thurman RG. 1994. Hepatic Ito cells contain calcium channels: Increases with transforming growth factor-beta 1. Hepatology 20:1009-1014.
38. Pfeilschifter J, D'Souza SM, Mundy GR. 1987. Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology 121:212-218.
39. Preston MR, el Haj AJ, Publicover SJ. 1996. Expression of voltage-operated Ca2+ channels in rat bone marrow stromal cells in vitro. Bone 19:101-106.
40. Roberts CJ, Birkenmeier TM, McQuillan JJ, Akiyama SK, Yamada SS, Chen WT, Yamada KM, McDonald JA. 1988. Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem 263:4586-4592.
41. Robey PG, Termine JD. 1985. Human bone cells in vitro. Calcif Tissue Int 37:453-460.
42. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB. 1987. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105:457-463.
43. Rooney TA, Sass EJ, Thomas AP. 1989. Characterization of cytosolic calcium oscillations induced by phenylephrine and vasopressin in single fura-2-loaded hepatocytes. J Biol Chem 264:17131-17141.
44. Sastry SK, Horwitz AF. 1996. Adhesion-growth factor interactions during differentiation: An integrated biological response. Dev Biol 180:455-467.
45. Schmidmaier G, Wildemann B, Ostapowicz D, Kandziora F, Stange R, Haas NP, Raschke M. 2004. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors. J Orthop Res 22:514-519.
46. Shah A, Hickok N, Chang R, Sinha R, Tuan R. 1997. TGF-b1 Enhances Osteoadhesive and osteomorphogenetic events of primary human osteoblasts on orthopaedic biomaterials. Mol Biol Cell 8:72a.
47. Shah AK, Lazatin J, Sinha RK, Lennox T, Hickok NJ, Tuan RS. 1999. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. Biol Cell 91:131-142.
48. Shao Y, Alicknavitch M, Farach-Carson MC. 2005. Expression of voltage sensitive calcium channel (VSCC) L-type Ca(v)1.2 (alpha(1C)) and T-type Ca(v)3.2 (alpha(1H)) subunits during mouse bone development. Dev Dyn 234:54-62.
49. Sinha RK, Tuan RS. 1996. Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 18:451-457.
50. Sinha R, Shah S, Tuan R. 1991. Cell spreading and attachment of human osteoblasts to metallic substrates. J Cell Biol 115:448a.
51. Sinha RK, Morris F, Shah SA, Tuan RS. 1994. Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Rel Res 305:258-272.
52. Thapa N, Kang KB, Kim IS. 2005. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone 36:232-242.
53. Tsien RY. 1989. Fluorescent indicators of ion concentrations. Methods Cell Biol 30:127-156.
54. Tsien RW, Hess P, McCleskey EW, Rosenberg RL. 1987. Calcium channels: Mechanisms of selectivity, permeation, and block. Annu Rev Biophys Biophys Chem 16:265-290.
55. Verschueren K, Huylebroeck D. 1999. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells. Cytokine Growth Factor Rev 10:187-199.
56. Wang JL, Lin KL, Chen JS, Lu YC, Jiann BP, Chang HT, Hsu SS, Chen WC, Huang JK, Ho CM, Jan CR. 2004. Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts. Biochem Pharmacol 67:1123-1130.
57. Wierda WG, Mehr DS, Kim YB. 1989. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay. J Immunol Methods 122:15-24.
58. Wildemann B, Schmidmaier G, Brenner N, Huning M, Stange R, Haas NP, Raschke M. 2004. Quantification, localization, and expression of IGF-I and TGF-beta1 during growth factor-stimulated fracture healing. Calcif Tissue Int 74:388-397.
59. Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J, Okazaki K. 2005. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 166:1029-1039.
60. Zahanich I, Graf EM, Heubach JF, Hempel U, Boxberger S, Ravens U. 2005. Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 20:1637-1646.